AbbVie Inc. — Earnings Quality Grade F
ABBV · Healthcare
Major red flags
Screening Summary
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 75 days, change +4 days YoY
AR growth 15.3% exceeds revenue growth 8.6%
Revenue 8.6%, CFFO 1.2%. Cash follows revenue
Expense Quality
Inventory 18.4% vs COGS 7.7%. Normal
CapEx growth 24.6% is >2x revenue growth 8.6%
SG&A/Gross Profit = 32.6%. Normal
Gross margin 70.2%, change +0.2pp. Stable
Cash Flow Quality
CFFO/NI = 4.50. Profits backed by cash
FCF $17.8B, FCF/NI = 4.22
Accruals ratio = -11.1%. Low accruals
Cash $5.3B covers only 8% of debt $67.5B
Balance Sheet Health
Goodwill+Intangibles $88.3B = -2700% of equity. Manageable
Debt/EBITDA = 3.8x. Healthy
Other assets 17.3% vs revenue 8.6%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -7% YoY. Normal
Manipulation Score
M-Score = -2.87 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-09